Item 5. Other Information
Item 5. Other Information.
None.
29
Item 6. Exhibits
Exhibit
No.
Description
31.1
Certification of Chief Executive Officer of the Company in accordance with Section 302 of the Sarbanes-Oxley Act
of 2002 (filed herewith).
31.2
Certification of Chief Financial Officer of the Company in accordance with Section 302 of the Sarbanes-Oxley Act
of 2002 (filed herewith).
32.1
Certification of Chief Executive Officer and Chief Financial Officer of the Company in accordance with Section 906
of the Sarbanes-Oxley Act of 2002 (filed herewith).
99.1
Press Release for Quarter Ended September 30, 2020 (filed herewith).
101.1
Interactive Data File
30
SIGNATURES
Pursuant to requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Fennec Pharmaceuticals Inc.
Date: November 16, 2020
By:
/s/ Rostislav
Raykov
Rostislav Raykov
Chief Executive Officer
(principal executive officer)
Date: November 16, 2020
By:
/s/ Robert Andrade
Robert Andrade
Chief Financial Officer
(principal financial and chief accounting officer)
31
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.